<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02349360</url>
  </required_header>
  <id_info>
    <org_study_id>201400370</org_study_id>
    <nct_id>NCT02349360</nct_id>
  </id_info>
  <brief_title>Safety, Tolerability and Host Response to Lactobacillus Johnsonii</brief_title>
  <acronym>LJ</acronym>
  <official_title>Safety, Tolerability and Host Response to Lactobacillus Johnsonii</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Juvenile Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to determine the effects of the probiotic,
      Lactobacillus johnsonii N6.2, on safety, gastrointestinal function, wellness, fecal bacteria
      and blood biomarkers in healthy individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy adult volunteers from 18-50 years of age will be recruited through the University of
      Florida and randomly distributed into two groups. This study is divided into 3 phases:
      baseline, intervention (study treatment) and washout. Participants will receive either the
      probiotic or placebo during the intervention phases. During the baseline phase, blood and
      fecal samples will be collected about 1 week before intervention initiation. On the day of a
      scheduled blood draw, the participant will need to arrive fasted overnight, and a light
      breakfast will be provided after blood draw. Starting on day 1 of the intervention phase, a
      second baseline blood sample will be collected and the participant will begin the study
      intervention (probiotic or placebo). Participants will consume 1 capsule (probiotic or
      placebo) daily for 8 weeks, and blood and stool samples will be collected and processed (on
      or around weeks 2, 4 and 8 of the intervention phase). A Fisher Scientific commode specimen
      collection system will be provided for stool collections. The stool collection kit may be
      taken home (participants will be asked to drop off the stool within 4 hours of defecation)
      for fecal sample collection or may use the restroom in the clinical lab at the Food Science
      and Human Nutrition Building in which kits will be provided for use. In the wash-out phase,
      participants will not consume the capsule (either the probiotic or placebo), but will provide
      blood and stool samples (on or around week 12). Throughout the study, participants will
      provide a total of 5 stool samples and 6 blood samples. Participants will be asked to
      complete daily and weekly questionnaires throughout all phases of the study, which will ask
      about quality of life (physical functioning, mental functioning, level of sleep, etc.),
      gastrointestinal function, and dietary intake. These assessments will be self-reported via
      online questionnaires. In the event that internet access is not available for a portion of
      the study, paper copies of the questionnaires may be provided.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Reporting Adverse Events</measure>
    <time_frame>13 weeks</time_frame>
    <description>The number of participants reporting Adverse Events was reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite Measure of Blood Chemistry Profiles</measure>
    <time_frame>13 weeks</time_frame>
    <description>Number of clinically relevant out of range values of the comprehensive metabolic panel and hemogram during intervention through washout period vs baseline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Encapsulated starch placebo administered for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>L. johnsonii N6.2</intervention_name>
    <description>L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks</description>
    <arm_group_label>Probiotic</arm_group_label>
    <other_name>Lactobacillus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Encapsulated starch placebo administered for 8 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To participate in the study individuals must

               -  be 18-50 years old.

               -  be willing to complete multiple questionnaires via computer.

               -  be willing to take the probiotic or placebo capsule daily for 8 weeks.

               -  be willing to provide 1 stool during weeks 0, 2, 4, 8 and 12 of the study.

               -  be willing to provide blood samples at weeks -1, 0, 2, 4, 8 and 12 of the study.

               -  have daily access to a computer with internet access for the entire 13-wk study.

               -  be willing to provide a social security number

        Exclusion Criteria:

          -  To participate in the study individuals must NOT

               -  currently take medications for constipation, diarrhea or psychological disorders
                  (depression, anxiety, insomnia etc.).

               -  have taken antibiotics within the past four weeks prior to randomization.

               -  currently take probiotic supplements and do not want to discontinue a minimum of
                  two weeks prior to the study

               -  have had or are currently being treated for any diseases or illnesses such as
                  gastrointestinal disease (gastric ulcers, Crohn's, ulcerative colitis, etc.),
                  chronic disease like diabetes or kidney disease, immune-compromising diseases or
                  conditions (HIV, AIDS, hepatitis, cancer, transplant patient etc.)

               -  currently receive medical treatment for stress induced symptoms/disorders

               -  be a current smoker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy J Dahl, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida, Food Science and Human Nutrition Dept</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2014</study_first_submitted>
  <study_first_submitted_qc>January 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2015</study_first_posted>
  <results_first_submitted>December 21, 2017</results_first_submitted>
  <results_first_submitted_qc>April 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">May 18, 2018</results_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>safety</keyword>
  <keyword>tolerability</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Probiotic</title>
          <description>L. johnsonii N6.2 in capsule form administered for 8 weeks
L. johnsonii N6.2: L. johnsonii N6.2 in capsule form administered for 8 weeks</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Encapsulated starch placebo administered for 8 weeks
Placebo: Encapsulated starch placebo administered for 8 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Probiotic</title>
          <description>L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks
L. johnsonii N6.2: L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Encapsulated starch placebo administered for 8 weeks
Placebo: Encapsulated starch placebo administered for 8 weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="21"/>
            <count group_id="B3" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23" lower_limit="18" upper_limit="36"/>
                    <measurement group_id="B2" value="21" lower_limit="18" upper_limit="48"/>
                    <measurement group_id="B3" value="21" lower_limit="18" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Adverse Events</title>
        <description>The number of participants reporting Adverse Events was reported.</description>
        <time_frame>13 weeks</time_frame>
        <population>Subjects completing the probiotic and the placebo intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic</title>
            <description>L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks
L. johnsonii N6.2: L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks (</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Encapsulated starch placebo administered for 8 weeks
Placebo: Encapsulated starch placebo administered for 8 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Adverse Events</title>
          <description>The number of participants reporting Adverse Events was reported.</description>
          <population>Subjects completing the probiotic and the placebo intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Measure of Blood Chemistry Profiles</title>
        <description>Number of clinically relevant out of range values of the comprehensive metabolic panel and hemogram during intervention through washout period vs baseline.</description>
        <time_frame>13 weeks</time_frame>
        <population>Subjects completing intervention and final blood draw after 4 week washout period.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotic</title>
            <description>L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks
L. johnsonii N6.2: L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks (</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Encapsulated starch placebo administered for 8 weeks
Placebo: Encapsulated starch placebo administered for 8 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Measure of Blood Chemistry Profiles</title>
          <description>Number of clinically relevant out of range values of the comprehensive metabolic panel and hemogram during intervention through washout period vs baseline.</description>
          <population>Subjects completing intervention and final blood draw after 4 week washout period.</population>
          <units>events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Probiotic</title>
          <description>L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks
L. johnsonii N6.2: L. johnsonii N6.2 10^10 CFU in capsule form administered for 8 weeks</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Encapsulated starch placebo administered for 8 weeks
Placebo: Encapsulated starch placebo administered for 8 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sinus Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Dental Abcess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fractured clavical</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Wendy Dahl Associate Professor</name_or_title>
      <organization>University of Florida</organization>
      <phone>3522943707</phone>
      <email>wdahl@ufl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

